Canada at risk of collateral damage in U.S. drug pricing war

A proactive and co-ordinated strategy from the Canadian government is essential to safeguard both access and affordability to pharmaceuticals for the long term.
Marjorie Michel
Health Minister Marjorie Michel, pictured. The federal government must develop a strategy—with input from frontline health care professionals including pharmacists—to protect access to and affordability of medication, writes Annette Robinson.

Canadians expect to walk into their pharmacy and get the medications they need, when they need them. However, one i...

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.


Already a Subscriber?

Get Weekend Point of View Newsletter

Top Canadian political and policy opinion and analysis. Saturdays and Sundays. Weekends.


By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy

MORE Opinion

RELATED STORIES